Combined Vorinostat, lenalidomide and dexamethasone therapy in patients with relapsed or refractory multiple myeloma: A Phase I study

Category Primary study
JournalHaematologica
Year 2009
This article has no abstract
Epistemonikos ID: d987a579fd26e0d5b6936f0abf500453e75d55e9
First added on: Feb 28, 2025